Stroke Timing Through a Circadian Lens: A Brain‐Centric Perspective

Circadian rhythms—the intrinsic 24-h cycles that regulate our physiological processes—play a profound role in metabolic and cardiovascular health. In stroke medicine, these rhythms influence the timing, severity, and outcomes of cerebrovascular events. As circadian biology moves from niche research into the mainstream of precision medicine, it offers a valuable opportunity to rethink how we prevent, treat, and rehabilitate stroke. Our recent narrative review explored the relationship between circadian rhythms and stroke [1]. Epidemiological data consistently show a morning peak in ischemic stroke incidence, driven by endogenous fluctuations in blood pressure, vascular tone, coagulation factors, and neurohormonal release—particularly cortisol, melatonin, catecholamines, and pro-inflammatory cytokines. In some populations, a secondary peak is observed later in the day, further suggesting that stroke risk is modulated by circadian biology [1]. This vulnerability is governed by the brain's central pacemaker—the suprachiasmatic nucleus (SCN)—which coordinates peripheral clocks throughout the body. Within the brain, glial cells and neural tissues have their own circadian machinery, regulating neurotransmission, inflammatory responses, and neurovascular stability [2]. When disrupted, these systems may heighten susceptibility to ischemic damage, positioning the brain not only as a regulator of circadian rhythms but also as a target of their dysfunction [1, 2]. Chronotherapy—the strategic alignment of medical treatment with biological timing—represents a growing frontier in stroke care. Administering antihypertensives, thrombolytics, or neuroprotective agents during optimal circadian windows could enhance efficacy and reduce side effects. The question is no longer only what to give, but when. Time is brain—but so is timing. Beyond urgency lies the recognition that the timing of intervention may critically shape outcomes. In this context, personalized medicine can benefit from factoring in chronotypes—whether a person is naturally inclined toward morning or evening activity. Evening chronotypes may face increased risks due to irregular sleep patterns, social jetlag, and metabolic disturbances—all of which are potentially modifiable factors influencing stroke vulnerability [3]. Circadian rhythms are also responsive to environmental cues. In rehabilitation, timing of sleep, light exposure, meals, and physical activity can act as “zeitgebers” that help restore biological rhythms [4]. Practices like morning walks, regular mealtimes, and appropriately scheduled exercise can reinforce neuroplasticity and recovery. Stroke rehabilitation, then, is not only about what we do, but when we do it [4]. However, the integration of circadian biology into routine stroke care is still emerging. Clinical pathways prioritize rapid action but often overlook chronobiological context. Important questions remain: Should thrombolysis be individualized based on circadian profiles? Could medications be scheduled to mitigate nocturnal blood pressure surges? Do circadian patterns influence rehabilitation outcomes? Multidisciplinary research is needed to address these issues, especially through time-sensitive clinical trials. The urgency of stroke is well captured by the phrase “time is brain”—but as chronobiology reveals, timing itself may be equally crucial. From onset to intervention to recovery, aligning our medical strategies with the body's internal clock could redefine stroke care. We urge researchers, clinicians, and policy-makers to recognize and harness this temporal dimension. By aligning medicine with time, we can reduce burden, improve outcomes, and bring stroke care into a more personalized and circadian-aware era. Sincerely, Bivek Singh Bivek Singh: conceptualization, writing – review and editing, writing – original draft, formal analysis. The author has nothing to report. The author has nothing to report. The author has nothing to report. The author declares no conflicts of interest. The author has nothing to report.